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Abstract 
Recently, the porous bioactive glasses have attracted a lot of attention for use as 
scaffolds for tissue engineering bone, such glasses include the high phosphate, 
strontium containing glass (Stronbone PTM). However, the previous studies suggest 
that strontium can have a detrimental effect on the ability of apatite-like phase 
formation of the glass. The previously studied high phosphate all Sr glass showed an 
unidentified phase rather than an apatite-like phase upon immersion. Octa-calcium 
phosphate (OCP) is believed to be a precursor phase to apatite, however octa-
strontium phosphate does not exist. Fluoride is known to knock out the OCP 
formation and promotes fluorapatite formation. This work presents the incorporation 
of a small amount of fluoride into calcium/strontium bioactive glasses. Differential 
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scanning calorimetry was used to estimate the glass thermal properties. All of the 
studied glass compositions were subjected to bioactivity studies in Tris buffer 
(pH=7.4) for up to 21 days. The initial glasses and the resultant precipitates were 
analysed using fourier transform infra red spectroscopy, X-ray diffraction and magic 
angle spinning-nuclear magnetic resonance. The findings showed that all the fluoride 
containing glasses were amorphous and there was a marked increase in the rate of 
apatite formation in vitro compared to the equivalent fluoride free glasses, 
particularly for the all strontium containing glass. This indicates that the presence of 
fluoride affects the pathway of apatite formation, forming fluorapatite directly instead 
of via the transformation from OCP to hydroxyapatite. Therefore, fluoride may have 
potential future clinical applications as an additive to increase apatite formation.     
Introduction  
 
There is considerable interest in developing porous bioactive glasses for the use as 
scaffolds for tissue engineering bone. A glass suitable for the use as a scaffold 
should fulfill the following criteria:  
1. It should be capable of being sintered by a viscous flow mechanism without 
crystallisation to give a three dimensional open porous structure with an 
interconnect size of at least 100 microns to facilitate infiltration by both blood 
vessels and osteoblasts. 
2. It should form an apatite-like layer on its surface.  
3. It should not result in a too high pH rise in vivo. 
4. It should actively stimulate the formation of new bone tissue and should 
osseointegrate. 
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5. It should promote angiogenesis. 
The strontium containing bioactive glass (SP-Ca/Sr, Stonbone PTM) given in Table 1 
exhibits these properties and shows rapid osseointegration and new bone formation 
in vivo (1). Strontium is known to up-regulate osteoblasts and down-regulate 
osteoclasts (2). Strontium is also slightly bactericidal (3) (4) and also of relatively 
high atomic number enabling the placement and resorption of strontium based 
biomaterials to be visualised using standard X-ray methods. Silicon released from 
bioactive glass has been shown to stimulate angiogenesis (3). Glass SP-Ca/Sr 
exhibits a large processing window defined as the onset temperature of 
crystallisation minus the glass transition temperature (Tconset-Tg). This large 
processing window of over 200oC enables the glass particles to be viscous flow 
sintered without crystallisation occurring. This enables the glass to be formed into 
porous structures by a variety of routes. The low alkali metal content and high 
phosphate content reduces the pH rise, whilst the high phosphate content is known 
to increase the amount of apatite formed and reduce the time to form apatite (5) (6). 
However, Sriranganathan et al. (7) found that the introduction of strontium has a 
detrimental effect on the apatite-like phase formation ability of the glasses. 
Sriranganathan et al. investigated the in vitro bioactivity of the glass given in Table 1 
and the equivalent glasses containing only calcium and no strontium and only 
strontium and no calcium (7). The all strontium high phosphate bioactive glass 
showed the glass to form a new unidentified phase upon immersion in Tris buffer. 
This new phase is not a strontium apatite (Sr10(PO4)6F2) or Collins salt 
(Sr6H3(PO4)5·2H2O) and has not been found previously. This phase seems to be a 
strontium orthophosphate, based on FTIR and 31P MAS-NMR data. We have termed 
this new unidentified phase as “X-phase”. In contrast, the related calcium containing 
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glass and mixed calcium/strontium glass form an apatite-like phase in both Tris 
buffer and simulated body fluid. The all strontium glass also forms an apatite-like 
phase in SBF though its identification is far from conclusive. It is thought that apatite 
formation goes via the formation of an octa-calcium phosphate precursor phase 
(Ca8(PO4)6H2.5H2O) if the pH <9 (8) (9). However, octa-strontium phosphate 
(Sr8(PO4)6H2.5H2O) does not exist (7). Consequently with the strontium bioactive 
glass it is thought that because the precursor phase can not form, that the formation 
of an apatite phase is not possible and the X-phase forms instead. In SBF, which 
contains calcium ions, the strontium containing glass degraded and resulted in octa-
calcium phosphate formation with possibly a small amount of strontium substituted 
for calcium in the octa-calcium phosphate lattice. Fluoride is known to knock out the 
OCP precursor phase and form an apatite directly (10). Brauer et al. (11) and 
Mneimne et al. (12) showed that fluoride containing bioactive glasses formed 
fluorapatite and that apatite formation was enhanced by the presence of fluoride. 
Their results (11) (12) can be explained by fluoride knocking out the precursor OCP 
phase and forming an apatite directly. The fluoride ion is smaller than hydroxyl ion 
and therefore the fluoride ion can fit into the space at the center of the Ca(II) triangle 
in the apatite crystal lattice and form a more stable fluorapatite compared with 
hydroxyapatite. There is little direct conclusive evidence for OCP formation with 
bioactive glasses. This is in part due to OCP and hydroxyapatite being very difficult 
to distinguish by fourier transform infrared spectroscopy or X-ray powder diffraction. 
OCP exhibits one characteristic diffraction line at 4.68o two theta with copper K-α X-
rays. Most studies in the literature do not access this very low two theta range. 
Furthermore OCP transforms readily to hydroxycarbonated apatite and the 4.68o two 
theta spacing corresponds to the large >2nm water layer which is very prone to 
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structural disorder and Scherrer line broadening. Fluoride is also known to knock out 
the formation of Collin’s salt and also cause the direct formation of apatite (10). 
Fluoride has been shown to not only knock out OCP as a precursor phase to apatite, 
but also inhibits the formation of Collin’s salt from strontium and phosphate 
containing solutions at pH=7.0, resulting in direct formation of a strontium fluoridated 
apatite (13). Feenstra et al. (13) also found that the fluoridated apatite formed 
exhibited very strong heterogenous nucleation and its formation exhibited a 
maximum with fluoride concentration in solution.  
Apart from promoting rapid fluorapatite formation, it is also shown that fluoride 
regulates bone-forming cell activities, promotes osteoblasts-like cell pre-osteogenic, 
pro-angiogenic responses and bone resorption in vitro (14) (15). Moreover, it is also 
found that fluoride enables to stimulate osteoblast mitosis and bone formation (16). 
Those benefits are favourable in the applications of bone substitutes.  
Based on these factors it was chosen to investigate bioactive glasses with small 
fluoride additions and evaluate their degradation and apatite formation abilities in 
Tris buffer. The hypothesis being that fluoride release from the bioactive glasses will 
prevent the formation of OCP and other phases like the Collin’s salt, the X-phase 
and form a fluoridated apatite directly, competing with the normal hydroxyapatite 
formation pathway (17). 
Materials and Methods  
The studied glasses were produced by a melt-quenched method in a similar way to a 
previous paper published by this research group, Sriranganathan et al. (7). The 
relevant oxides and fluorides were mixed and melted at the appropriate firing 
temperature shown in Table 1 for 1 hour in a platinum crucible. Different 
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temperatures were used to account for the contrasting effects of strontium and 
fluorine on the melting temperature of the glasses (18). After 1 hour melting, 
deionised water was used to quench the glass and the resultant coarse powder 
glass was collected, dried overnight and ground into powder using a Gy-Ro Mill 
(Glen Creston Ltd, Twickenham UK). An Endecotts EFL 2000/1 automated sieve 
shaker was used to separate the powder into a fine (<38 µm) and coarse powder. A 
Stanton Redcroft DSC 1500 (Rheometric Scientific, Epsom, UK) was then used to 
analyse the fine and coarse powder to determine the glass transition temperature 
(Tg), crystallisation onset temperature (Tconset), processing window (defined as Tconset-
Tg) and crystallisation peak termperature (Tc) with an accuracy of ±5 °C. 
Table 1. Glass composition (mol%), network connectivity (NC) and glass firing 
temperature (°C) 
Glass SP-Ca/Sr SP-Ca SP-Sr SPF-Ca/Sr SPF-Ca SPF-Sr 
SiO2 44.5 44.5 44.5 43.63 43.63 43.63 
P2O5 4.5 4.5 4.5 4.41 4.41 4.41 
Na2O 4 4 4 3.92 3.92 3.92 
K2O 4 4 4 3.92 3.92 3.92 
CaO 17.8 35.6 0 17.45 34.90 0 
SrO 17.8 0 35.6 17.45 0 34.90 
MgO 7.5 7.5 7.5 7.35 7.35 7.35 
CaF2 0 0 0 1.96 1.96 1.96 
NC 2.31 2.31 2.31 2.2 2.2 2.2 
Tfiring 1460 1450 1470 1450 1440 1460 
 
The acellular ‘bioactivity’ test was conducted at 37°C in an incubator with a rotational 
speed of 60rpm, using 150mg fine glass powder incubated for periods of 1,3,7, 14 
and 21days in 100ml of Tris buffer solution (19). After the various time intervals 
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passed the solution was filtered and refrigerated prior to analysis. The collected 
precipitates were dried for 24 hours in an oven at 37°C and then investigated for their 
glass degradation and apatite formation abilities using X-ray Diffraction (XRD), 
Fourier Transform Infrared (FTIR) and 31P and 19F Magic Angle Spinning-Nuclear 
Magnetic Resonance (MAS-NMR).  
XRD and FTIR experiments were carried out as previously described (20) using an 
X’Pert Pro X-ray diffractometer (PANalytical, The Netherlands) and a FTIR 
Spectroscopy (Spectrum GX, Perkin-Elmer, Cambridge, UK), respectively. 
31P and 19F MAS-NMR spectra were acquired on a Bruker Avance 600 MHz 
spectrometer at resonance frequencies of 242.9 MHz and 564.7 MHz respectively. 
31P MAS-NMR spectra were acquired in a 4 mm zirconia rotor at a spinning speed of 
12 kHz, with a recycle delay of 60 s. A total of 32 or 64 scans were used. The 
chemical shifts were referenced using 85% H3PO4 to 0 ppm. 19F MAS-NMR 
experiments were carried out in a 2.5 mm zirconia rotor at a spinning rate of 21 KHz. 
The spectra were recorded after 560 scans and 60 seconds relaxation. Sodium 
fluoride 1M aqueous solution producing a sharp signal at -120 ppm was used as a 
secondary reference against CFCl3. 
Results and Discussion  
All the glasses were optically clear and amorphous by XRD (Figure 1). The 
maximum in the amorphous scattering shifted to lower two theta values with 
increasing strontium content as found previously for a number of bioactive glass 
series where strontium has been substituted for calcium (21) (22) (23) (24) (25) (26). 
This is consistent with the larger size of the Sr2+ (1.18 Å) compared to Ca2+ (1.00 Å) 
(27) 
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Figure1: XRD patterns of glasses SPF-Ca, SPF-Ca/Sr and SPF-Sr.   
 
Glass thermal properties were analysed by DSC. The obtained Tg values, onset 
temperatures for crystallisation (Tconset) and crystallisation temperatures (Tc1 and Tc2) 
are summarised in Table 2. The Tg values decrease with increasing Sr content. This 
matches with the finding by Fredholm et al. (21) and Kie et al. (23) showing that Tg 
decreases with strontium substitution for calcium. The Tg values are close to those 
predicted by Brauer and Hill (28). Incorporation of fluoride decreases the Tg by 20-
30oC compared to the previously studied glasses (7). The DSC traces of 
compositions SP-Ca and SPF-Ca are presented as examples in Figure 2. The 
fluoride containing glasses exhibit an additional small crystallisation exotherm at a 
lower temperature than the equivalent fluoride free glasses, which is likely to be 
associated with the fluoride addition and the formation of a fluoride containing crystal 
phase. The first peak crystallisation temperature also reduces with Sr content in a 
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similar fashion to Tg. XRD results of heat-treated fluoride containing glasses from 
Chen et al. (29) showed the first crystallisation process to correspond to the 
formation of a fluorapatite, which is not surprising given the low alkali metal content. 
The processing window defined as the onset temperature for crystallisation minus 
the Tg (30) reduces on incorporating CaF2, but is still over 120°C. A large processing 
window facilitates viscous flow sintering well above the Tg without crystallisation 
occurring and is important for the synthesis of porous scaffolds. The large reduction 
in the heat flux after Tg with the fine powder (<38µm) did not occur with 1-2mm glass 
particles. This change is associated with the viscous flow sintering of the fine glass 
particles and a change in the heat flux associated with sintering. This change in the 
heat flux is much greater in the fluoride free glass than in the fluoride containing 
glass , which again indicates that the fluoride containing glass does not sinter so 
readily as the equivalent fluoride free glass. Similar behaviours were found for the 
compositions of SPF-Ca/Sr and SPF-Sr. 
Table 2. Tg values, onset temperatures for crystallisation (Tconset) and 
crystallisation temperatures Tc1 and Tc2  for glasses. 
 
 Tg (oC) Tconset (oC) Tc1 (oC) Tc2 (oC) Tconset-Tg (oC) 
SPF-Ca <38µm 596 717 801 874 121 
SPF-Ca Frit 591 782 819 926 191 
SPF-Ca/Sr <38µm 570 687 770 899 117 
SPF-Ca/Sr Frit 569 771 811 914 weak 202 
SPF-Sr <38µm 562 703 740 824 141 
SPF-Sr Frit 559 708 743 906 184 
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Figure 2: DSC traces for glass powder (<38µm) of the all calcium glasses with 
and without fluoride (SPF-Ca and SP-Ca).  
 
The XRD patterns of the all Ca glass (SPF-Ca) after immersion in Tris buffer for 
periods up to 14 days are shown in Figure 3a. Diffraction peaks at approximately 
25.8 and 30-33o two theta corresponding to the principal diffraction lines for 
fluorapatite are present after 1 day. There is also the loss of the original amorphous 
scattering from the glass and the development of a broad peak at 20-23o two theta 
corresponding to silica-gel formation. Here, no significant difference in the peak 
intensity with increasing in immersion time up to 14 days was noticed, indicating 
rapid apatite formation. Similar results were found for the mixed glass (SPF-Ca/Sr) 
and the all Sr glass (SPF-Sr, in Figure 3b), but the strontium substituted fluorapatite 
did not form until 7 days in the latter. The apatite diffraction lines intensified with an 
increase in immersion time up to 14 days, suggesting the formation of a more 
ordered apatite with time.   
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Figure 3: XRD patterns of glasses (a) SPF-Ca and (b) SPF-Sr after immersion in 
Tris Buffer for 0, 1,3,7 and 14 days.  
 
Figure 4 compares the XRD patterns of the studied glasses after 7 days immersion 
in Tris buffer. It is clear that the all Ca glass shows the most pronounced apatite 
diffraction lines, matching that of Ca10(PO4)6F2 (00-034-0011). On incorporating Sr, 
the diffraction lines are less distinct and the XRD patterns are composed of both 
residual glass and the formed apatite. This is in agreement with previous study of the 
substitution of Sr with Ca in fluoride free glasses by Sriranganathan et al. (7), which 
shows that the introduction of Sr retards glass degradation and apatite formation. In 
the case of the all Sr glass, the developed diffraction lines largely match the principal 
diffraction lines for Sr10(PO4)6F2 (00-050-1744). Taking a careful look at the patterns, 
the diffraction peaks shift to slightly lower two theta values with increasing strontium 
content in the glass. Here, the Ca10(PO4)6F2 is expected to be formed in glass SPF-
Ca, while the mixed (Ca/Sr)10(PO4)6F2 and Sr10(PO4)6F2 phases are expected to form 
in SPF-Ca/Sr and SPF-Sr respectively. 
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Figure 4: Comparison of XRD patterns after 7 days immersion in Tris Buffer for 
glasses SPF-Ca, SPF-Ca/Sr and SPF-Sr (Ca10(PO4)6F2 (●): 00-034-0011; 
Sr10(PO4)6F2 (*): 00-050-1744). 
 
Figure 5 compares the diffraction patterns obtained for the all strontium glass with 
and without fluoride after 14 days immersion. In the absence of fluoride apatite does 
not form and the unidentified highly crystalline strontium orthophosphate phase 
forms (5). In contrast, with the small addition of fluoride the diffraction pattern 
corresponds to that of strontium fluorapatite.  
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Figure 5: Comparison of XRD patterns after immersion in Tris Buffer for SPF-
Sr and SP-Sr in Tris 14 days.The FTIR spectra of all Ca and all Sr glasses before 
and after immersion in Tris buffer are shown in Figure 6a and 6b. For the initial 
glasses, there is a broad feature corresponding to the P–O bending mode and also a 
Si–O–Si bending vibration in the region 500–600 cm-1 (31) (21). The band around 
840 cm-1 in the glass spectra is due to Si–O-2NBO functional group (Q2) (21) . The 
dominant bands at approximately 910 and 990 cm-1 are attributed to Si–O (Q2) and 
Si–O–Si stretching vibrations respectively (31) (21). 
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Figure 6: FTIR spectra of (a) SPF-Ca and (b) SPF-Sr after immersion in Tris 
Buffer for 0, 1,3,7 and 14 days.  
Upon immersion in Tris buffer, the glass degradation leads to a reduction in the 
intensity of Q2 vibration band at 910 cm-1. In addition, the typical apatite split peaks 
at 560 and 605 cm-1 appear corresponding to a crystalline orthophosphate or apatite 
that is seen in the XRD after 1 day immersion for the all Ca glass and 7 days for the 
mixed glass and the all Sr glass, indicating rapid apatite formation (32).  
Figure 7(a) displays the 31P MAS-NMR spectra of the as-quenched fluoride 
containing glasses. All the spectra exhibit a broad peak corresponding to amorphous 
sodium/calcium/strontium orthophosphate. With the substitution of Ca with Sr, the 
chemical shifts increase progressively from 3.5 ppm to 4.4 ppm, attributed to the 
lower charge-to-size ratio of the strontium cation relative to calcium (23). Figure 7(b) 
presents the 31P NMR spectra of SPF-Ca immersed in Tris up to 21 days. It is 
interesting to note that after immersion the isotopic chemical shift of the spectra shift 
towards 2.8 ppm as a result of forming calcium orthophosphate and the linewidth of 
the spectra reduced gradually with an increase in immersion time indicating rapid (1 
day) apatite-like phase formation and the formation of a more ordered apatite with 
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increasing in immersion time. Similar changes are noticed in the Figure 7(c) and (d) 
for SPF-Ca/Sr and SPF-Sr. Moreover, the linewidth of the all calcium glass after a 
period of immersion are much narrower than the equivalent Sr containing glasses, 
confirming a more rapid apatite formation in the glass with the absence of Sr. This is 
in agreement with previous studies by Sriranganathan et al. (7) revealing that Sr 
retards apatite-like phase formation.  
(a) (b) 
  
(c) (d) 
  
 
Figure 7: 31P MAS-NMR spectra of (a) the fluoride containing glasses; (b) SPF-
Ca glass immersed in Tris up to 21 days; (c) SPF-Ca/Sr glass immersed in Tris 
up to 21 days; (d) SPF-Sr glass immersed in Tris up to 21 days 
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Figure 8 show the 19F MAS-NMR spectra of the glasses and the glasses after 21 
days immersion in Tris buffer solution. The three glass spectra show the presence of 
a series of broad overlapping peaks corresponding to mixed F-M(n) species, where 
M is largely Ca/Sr and Na. Brauer et al. (28) showed that F was complexed by Ca 
and Na with mixed F-Ca/Na(n) species present, whilst Chen et al. (29) showed that 
F-Ca(n) species were present in sodium-free fluoride containing glasses. It is clear 
that the spectra move to a higher chemical shift with increasing Sr content. The all 
Ca glass exhibits a peak at about -100 ppm while the all Sr glass one at – 83.2 ppm 
and the mixed one sits in between. This is due to the fact that Sr2+ cation is larger 
than the Ca2+ cation and the different shieling effects of two cations. After 21 days 
immersion, the broad peak from the original glass disappeared and new peaks 
emerged. In the case of the all Ca glass, an asymmetric peak develops at -102.5 
ppm assigned to the F-Ca(3) site in calcium fluroapatite (29), while the broad 
shoulder at -90 ppm could be indicative of the existence of residual glass, but is 
more likely an interstitial fluoride ion associated with B type carbonate substitution 
(CO3F)3- (33). In the case of the all Sr glass, two peaks appear at about -67 ppm, 
corresponding to F-Sr(3) site in strontium fluroapatite and -85 ppm which probably 
again corresponds to an interstitial fluoride ion associated with B type carbonate 
substitution (33). For the mixed Ca and Sr glass, multiple peaks are present that are 
not fully resolved at -75, -91.8 and -108 ppm after 21 days immersion. These peaks 
correspond to the presence of mixed sites, such as F-CaSr(2), (predicted at -79ppm) 
F-Ca(2)Sr (predicted at -91ppm) species in mixed calcium/strontium fluroapatites 
and F-Ca(3) species. This is in good agreement with the previous study by Hill et al. 
(34) which showed that upon heat treatment, that a calcium glass crystalised to 
calcium fluroapatite while the fully strontium substituted glass crystallised to 
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strontium fluoapatite and the mixed calcium strontium glass crystallised to mixed 
calcium/strontium fluroapatites.    
 
Figure 8. 19F MAS-NMR spectra of the as-quenched fluoride containing glasses 
and after immersion in Tris for 21 days, the asterisks represent the spinning 
side bands. 
The XRD, FTIR, 31P and 19F NMR consistently reveal that the introduction of fluoride 
into calcium and strontium glasses promotes and speeds up the apatite formation 
significantly compared with the equivalent fluoride free glasses studied by 
Sriranganathan et al. (7).  It is interesting and important to note that the incorporation 
of fluoride into the calcium free glass SP-Sr knocks out the formation of the X phase. 
In this glass it appears as if 2 mol% CaF2 is sufficient to inhibit the formation of the X 
phase and promote the formation of fluorapatite. This is significant as the retardation 
of apatite formation caused by a high concentration of strontium is a limiting factor in 
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its use in commercial bioactive glass formulations. Based on this in vitro study in 
Tris, fluoride is found to act independently of strontium to increase apatite formation. 
Although, the presence of fluoride also has some undesirable effects such as 
reducing the size of the sintering window, which will impede sintering and the 
synthesis of amorphous porous scaffolds. However, the sintering window is still over 
100 °C.  
It is important to note that in vivo there will always be a continuous turnover of 
calcium rich body fluids and a readily available supply of calcium ions, which will 
favour apatite formation. This effect is not included in the present study nor is it 
included in the widely used Simulated Body Fluid test developed by Kokubo.   
Conclusion  
The incorporation of fluoride leads to a reduction in Tg, Tc and the sintering window. 
In this in vitro study small additions of fluoride act independently to increase apatite 
formation with both strontium free and strontium containing bioactive glasses, 
counteracting the negative effects that strontium has on apatite formation. The effect 
of fluoride is most pronounced in the all strontium glass, which formed a strontium 
fluorapatite. The fact that fluoride promotes apatite formation in all the glasses and 
especially the all strontium one supports the hypothesis that apatite formation occurs 
via an OCP precursor phase in bioactive glasses and that strontium suppresses the 
formation of apatite, since octa-strontium phosphate cannot form. Moreover, the 
incorporation of fluoride knocks out the formation of OCP and results in the direct 
formation of fluorapatite. As a consequence of this, fluoride can be used as a 
promising additive to increase the apatite formation with bioactive glasses for tissue 
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engineered scaffolds and this is particularly beneficial where it is undesirable for the 
pH to increase to high values. 
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